Browsing Tag
Soleno Therapeutics
5 posts
Prader-Willi syndrome: What families need to know about causes, care, and the treatment breakthrough that just changed everything
Prader-Willi syndrome explained for families and carers: causes, diagnosis, care, the 2025 FDA approval of Vykat XR, and what the latest trials mean for treatment.
Could Neurocrine’s $2.9bn Soleno deal turn VYKAT XR into its next rare-disease blockbuster?
Neurocrine is buying Soleno for $2.9 billion to add VYKAT XR. Read what the deal means for NBIX growth, rare-disease strategy, and investor sentiment.
Top US stocks crash as inflation shock and tariff war fuel Wall Street’s worst day in months
US stocks tumbled on April 8 as inflation data and escalating US-China tariffs triggered sharp losses in biotech, AI, lithium, and semiconductor stocks.
Harmony Gold, MicroAlgo, and W. R. Berkley lead US stock gains on 28 March 2025
US stocks surged on 28 March 2025, led by gold miners, AI tech firms, and biotech companies. Find out which stocks soared and what it means for investors.
Top U.S. Stock Gainers on March 27: Concentrix, Soleno Therapeutics, and Dollar Tree lead the market
Concentrix, Soleno Therapeutics, and Dollar Tree lead U.S. stock gains on March 27, 2025. Find out what’s driving their rally and market trends.